Ameriprise’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Ameriprise’s Portfolio IPCI Stock Details IPCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2,000	Closed	-$59K	–	4046
2015 Q2	$59K	Sell	2,000 -2,000	-50%	-$60.4K	﹤0.01%	3951
2015 Q1	$112K	Hold	4,000	–	–	﹤0.01%	3670
2014 Q4	$90K	Buy	4,000 +1,000	+33%	+$27K	﹤0.01%	3597
2014 Q3	$90K	Hold	3,000	–	–	﹤0.01%	3720
2014 Q2	$114K	Hold	3,000	–	–	﹤0.01%	3536
2014 Q1	$132K	Sell	3,000 -1,000	-25%	-$40K	﹤0.01%	3396
2013 Q4	$148K	Buy	+4,000	New	+$107K	﹤0.01%	3257

Other funds holding IPCI

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FFA

First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return

FMBTD

First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return

NCCM

Nine Chapters Capital Management Short Hills, New Jersey $45.4M AUM 14.43% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Ameriprise's IPCI Position: Q3 2015 in Review

Ameriprise sold out of Intellipharmaceuticals International Inc. (IPCI) in Q3 2015, closing a stake of 2,000 shares — an estimated $59K sold.

Ameriprise first reported a position in IPCI in Q4 2013 and held it in 7 quarters. The position peaked at $148K in Q4 2013. 18 funds tracked by Wall St. Rank hold IPCI as of Q3 2015.

Ameriprise reported no remaining Intellipharmaceuticals International Inc. position as of Q3 2015 after selling out during the quarter.
Ameriprise sold 2,000 Intellipharmaceuticals International Inc. shares in Q3 2015, an estimated $59K.
Ameriprise first reported a position in Intellipharmaceuticals International Inc. in Q4 2013 and held it in 7 quarters.
Ameriprise's Intellipharmaceuticals International Inc. position peaked at $148K in Q4 2013.
18 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q3 2015.

Based on Ameriprise's 13F filing for Q3 2015, filed 12 Nov 2015.